Relapsed Ewing Sarcoma
5 clinical trials · Condition
◉ Watch Relapsed Ewing Sarcoma
| Record | Firm | Date |
|---|---|---|
| Cabozantinib With Topotecan-Cyclophosphamide (NCT04661852) | Dana-Farber Cancer Institute | 2020-12-23 |
| C7R-GD2.CART Cells for Patients With Relapsed or Refractory Neuroblastoma and Other GD2 Positive Cancers (GAIL-N) (NCT03635632) | Baylor College of Medicine | 2019-04-23 |
| A Study of INCB059872 in Relapsed or Refractory Ewing Sarcoma (NCT03514407) | Incyte Corporation | 2018-06-27 |
| Eurosarc Trial of Linsitinib in Advanced Ewing Sarcoma (NCT02546544) | University of Oxford | 2014-03-01 |
Track Relapsed Ewing Sarcoma automatically
Every clearance here is in the API, with alerts when new ones post.